Structure

InChI Key DDINXHAORAAYAD-UHFFFAOYSA-N
Smile CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21
InChI
InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C36H51Cl2N3O4
Molecular Weight 660.73
AlogP 8.68
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 19.0
Polar Surface Area 62.32
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 45.0

Pharmacology

Action Mechanism of Action Reference
PARTIAL AGONIST Dopamine D2 receptor partial agonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psychotic Disorders 1 D011618 ClinicalTrials

Related Entries

MCS

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
25.76
General disorders and administration site conditions
19.65
Injury, poisoning and procedural complications
16.65
Nervous system disorders
11.51
Investigations
3.16
Product issues
2.95
Gastrointestinal disorders
2.91
Musculoskeletal and connective tissue disorders
2.62
Skin and subcutaneous tissue disorders
2.61
Vascular disorders
2.18

Cross References

Resources Reference
CAS NUMBER 1259305-29-7
ChEBI 90930
ChEMBL CHEMBL2219425
DrugBank DB14185
DrugCentral 5052
EPA CompTox DTXSID60154997
FDA SRS B786J7A343
PharmGKB PA166161216
PubChem 49831411
SureChEMBL SCHEMBL1044330
ZINC ZINC000095564895